Applied dna announces pricing of $15 million registered direct offering priced at-the-market under nasdaq rules

Stony brook, n.y.--(business wire)---- $apdn--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 1,810,000 shares of common stock at a price of $8.30 per share, priced at-the-market under nasdaq rules, in a registered direct offering, resulting in total gross proceeds of approximat
APDN Ratings Summary
APDN Quant Ranking